CoChat

Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection

Markowitz, Norman, Quinn, Edward L., Saravolatz, Louis D. · 1992 · Annals of Internal Medicine

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To compare trimethoprim-sulfamethoxazole (TMP-SMZ) and vancomycin regarding efficacy and safety in the therapy of serious Staphylococcus aureus infections. DESIGN: Randomized, double-blind comparative trial. SETTING: A tertiary-care hospital. PATIENTS: One hundred and one intravenous drug users hospitalized with S. aureus infection. MEASUREMENTS: Cure and failure rates; blood and wound cultures; minimum inhibitory and bactericidal concentrations; serum inhibitory and bactericidal titers; temperature; leukocyte count; durations of treatment and hospitalization; and toxicity. RESULTS: Of 228 intravenous drug users, 101 had S. aureus infection and were included in the efficacy analysis (43 received TMP-SMZ and 58 received vancomycin). Methicillin-resistant S. aureus (MRSA) accounted for 47% of S. aureus isolates, and 65% of patients were bacteremic. Infections were cured in 57 of 58 vancomycin recipients and in 37 of 43 TMP-SMZ recipients (P less than 0.02). Failure occurred mostly in patients with tricuspid valve endocarditis and only in those with infection caused by methicillin-sensitive S. aureus (MSSA). The mean duration of bacteremia was 6.7 days in TMP-SMZ recipients and 4.3 days in vancomycin recipients. Among 222 subjects hospitalized for at least 24 hours, toxicity rates were similar for TMP-SMZ (23%) and vancomycin (20%) recipients; nausea and vomiting were associated with TMP-SMZ and inflammation at the intravenous site was associated with vancomycin. Forty-four percent of TMP-SMZ recipients and 29% of vancomycin recipients experienced side effects in the efficacy cohort (P greater than 0.05). CONCLUSIONS: Vancomycin is superior to TMP-SMZ in efficacy and safety when treating intravenous drug users who have staphylococcal infections. However, all treatment failures occurred in patients with MSSA infection at any site. Therefore, TMP-SMZ may be considered as an alternative to vancomycin in selected cases of MRSA infection.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-5-390

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 8

  1. Pugsley D, 1969, Postgrad Med J., 45, 95
  2. Bernstein-Hahn L, 1969, Paraplegia., 7, 96
  3. Bernstein-Hahn L, 1971, Int Surg., 46, 8
  4. Rosaschino F, 1973, Trimethoprim/sulphamethoxazole in Bacterial Infections. An International Symposium in Sardinia, April 26-27, 1972., 165
  5. Goodwin N, 1973, S Air Med J., 47, 2159
  6. Muangman V, 1973, J Med Assoc Thailand., 56, 448
  7. Bajpai J, 1977, Int Surg., 62, 172
  8. 10.1001/jama.1983.03330440050032 · doi:10.1001/jama.1983.03330440050032

Cited by

See all 343

Metadata

Authors
Markowitz, N., Quinn, E. L., & Saravolatz, L. D.
Affiliations
Henry Ford Hospital (US)
Venue
Annals of Internal Medicine
Published
1992-09-01
Volume
117
Issue
5
Pages
390-398
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2043567648
Cited by
343
References
57
Citations by year
2024: 9 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 9 · 2017: 9 · 2016: 5 · 2015: 16 · 2014: 16 · 2013: 5 · 2012: 12
FWCI
5.81
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
trimethoprim-sulfamethoxazole, vancomycin, Staphylococcus aureus infection, methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, people who inject drugs, bacteremia, tricuspid valve endocarditis, antibiotic efficacy, drug toxicity, duration of bacteremia
MeSH terms
Adult, Bacteriophage Typing, Double-Blind Method, Female, Humans, Male, Microbial Sensitivity Tests, Prospective Studies, Staphylococcal Infections, Vancomycin, Trimethoprim, Sulfamethoxazole Drug Combination, Substance Abuse, Intravenous, Methicillin Resistance, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection. https://app.cochat.ai/papers/10.7326/0003-4819-117-5-390
The paper
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992). Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-117-5-390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.